← Leaderboard
RARE
Ticker
RARE
Congressional Trades
10
by 1 members
Ticker Intelligence Brief
Who in Congress traded RARE, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Gilbert Cisneros
BUY · 2026-03-03
Largest range
$1K – $15K
Gilbert Cisneros
Slowest filing
38d
Gilbert Cisneros
Best vs SPY
22.8%
Gilbert Cisneros
Buys
10
100%
Sells
0
0%
Total Volume
$80K
midpoint
Unique Traders
1
members
Party Breakdown
Democrats10 · 100%
Republicans0 · 0%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
4▲
Jul '25
—
2▲
Aug '25
—
2▲
Feb '26
—
2▲
Mar '26
—
Democrats10▲0▼Net buyers
vs
Republicans0▲0▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-20$10KULTRAGENYX PHARMACEUTICALIssues related to drug development and market access.
- 2026-04-20$0ULTRAGENYX PHARMACEUTICALn/a termination report
- 2026-04-20$0ULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access.
- 2026-04-17$440KULTRAGENYX PHARMACEUTICAL INC.Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
- 2026-04-17$60KULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025. FY 2027 Appropriations.
- 2026-04-17$0ULTRAGENYX PHARMACEUTICALIssues related to drug development and market access.
- 2026-03-30$0ULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access.
- 2026-01-16$130KULTRAGENYX PHARMACEUTICAL INC.Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
- 2026-01-16$60KULTRAGENYX PHARMACEUTICAL INC.Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025.
- 2026-01-15$38KULTRAGENYX PHARMACEUTICAL- ultrarare disease - newborn screening - pediatric priority review voucher
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▲100
10 buys10 total0 sells
$80K buys · $0 sells
Cumulative Net Position (buy vol − sell vol)
+$80K
2025-0710 trades plotted2026-03
Timing Fingerprint
filing delay vs. excess return over SPY · 6 tradesCongress avg +1.6% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
67% of trades beat SPYavg excess +1.6%avg delay 29d6 buys0 sellsBuySellOther· dot size ∝ trade size
Trade Activity Timeline
Congressional buys & sells by month · last 4 months w/ activity
25/07
25/08
26/02
26/03
BuysSellsOtherHigh-volume month
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jul · Peak sell month: Jan
Congressional Conviction Timeline
net positioning · alpha track recordBULLISH10 buys0 sellscumulative α +9.7%4mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 36d | receipt → |
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 35d | receipt → |
| 2026-02-18 | DGilbert Cisneros | BUY | $1K – $15K | 20d | receipt → |
| 2026-02-18 | DGilbert Cisneros | BUY | $1K – $15K | 19d | receipt → |
| 2025-08-08 | DGilbert Cisneros | BUY | $1K – $15K | 38d | receipt → |
| 2025-08-08 | DGilbert Cisneros | BUY | $1K – $15K | 35d | receipt → |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 31d | receipt → |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 30d | receipt → |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 29d | receipt → |
| 2025-07-15 | DGilbert Cisneros | BUY | $1K – $15K | 29d | receipt → |